Estela Rodriguez, Associate Director of Community Outreach and Co-Lead of the Thoracic Site Disease Group of the Sylvester Comprehensive Cancer Center, shared an article on X authored by Amanda Lindberg et al.:
“This study proposes a diagnostic shift from static biomarker quantification in pts with NSCLC to assessing active immune pathways to provide more precise ICI treatment. Ultimately, the results implicate a need for combination diagnostics and therapies.”
Authors: Amanda Lindberg et al.
